Liu J, Zhang Y, Yu W, Sun L, Hu J, Jiang Y
Osteoporos Int. 2025; .
PMID: 39994027
DOI: 10.1007/s00198-025-07423-2.
Farlay D, Cornier M, Rizzo S, Cormier-Daire V, Charpie M, Pinto G
JBMR Plus. 2025; 9(2):ziae161.
PMID: 39822213
PMC: 11736749.
DOI: 10.1093/jbmrpl/ziae161.
Zhou W, van de Laarschot D, van Rooij J, Koedam M, Nguyen H, Uitterlinden A
J Bone Miner Res. 2024; 40(1):69-78.
PMID: 39485938
PMC: 11700580.
DOI: 10.1093/jbmr/zjae175.
Misof B, Fratzl-Zelman N
Calcif Tissue Int. 2024; 115(6):777-804.
PMID: 39231826
DOI: 10.1007/s00223-024-01263-8.
Wu Z, Li W, Jiang K, Lin Z, Qian C, Wu M
MedComm (2020). 2024; 5(8):e657.
PMID: 39049966
PMC: 11266958.
DOI: 10.1002/mco2.657.
Combining anabolic loading and raloxifene improves bone quantity and some quality measures in a mouse model of osteogenesis imperfecta.
Creecy A, Segvich D, Metzger C, Kohler R, Wallace J
Bone. 2024; 184:117106.
PMID: 38641232
PMC: 11130993.
DOI: 10.1016/j.bone.2024.117106.
Medical Management for Fracture Prevention in Children with Osteogenesis Imperfecta.
Arundel P, Bishop N
Calcif Tissue Int. 2024; 115(6):812-827.
PMID: 38553634
PMC: 11606989.
DOI: 10.1007/s00223-024-01202-7.
Effects of novel raloxifene analogs alone or in combination with mechanical loading in the Col1a2 murine model of osteogenesis imperfecta.
Kohler R, Creecy A, Williams D, Allen M, Wallace J
Bone. 2023; 179:116970.
PMID: 37977416
PMC: 10843597.
DOI: 10.1016/j.bone.2023.116970.
Characterizing Bone Phenotypes Related to Skeletal Fragility Using Advanced Medical Imaging.
Whittier D, Bevers M, Geusens P, van den Bergh J, Gabel L
Curr Osteoporos Rep. 2023; 21(6):685-697.
PMID: 37884821
PMC: 10724303.
DOI: 10.1007/s11914-023-00830-6.
Vitamin D and Osteogenesis Imperfecta in Pediatrics.
Coccia F, Pietrobelli A, Zoller T, Guzzo A, Cavarzere P, Fassio A
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242473
PMC: 10221881.
DOI: 10.3390/ph16050690.
Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta.
Liu W, Lee B, Nagamani S, Nicol L, Rauch F, Rush E
J Clin Endocrinol Metab. 2023; 108(7):1787-1796.
PMID: 36658750
PMC: 10271227.
DOI: 10.1210/clinem/dgad035.
Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta.
Hedjazi G, Guterman-Ram G, Blouin S, Schemenz V, Wagermaier W, Fratzl P
Bone. 2022; 162:116451.
PMID: 35654352
PMC: 11162744.
DOI: 10.1016/j.bone.2022.116451.
Dissecting the phenotypic variability of osteogenesis imperfecta.
Garibaldi N, Besio R, Dalgleish R, Villani S, Barnes A, Marini J
Dis Model Mech. 2022; 15(5).
PMID: 35575034
PMC: 9150118.
DOI: 10.1242/dmm.049398.
Bisphosphonate Treatment Alters the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta: A Pilot Study.
Sithambaran S, Harrison R, Gopal-Kothandapandi S, Rigby A, Bishop N
JBMR Plus. 2022; 6(3):e10592.
PMID: 35309861
PMC: 8914162.
DOI: 10.1002/jbm4.10592.
Bone Organic-Inorganic Phase Ratio Is a Fundamental Determinant of Bone Material Quality.
Luo Y, Amromanoh O
Appl Bionics Biomech. 2021; 2021:4928396.
PMID: 34754330
PMC: 8572605.
DOI: 10.1155/2021/4928396.
Multiscale characterization of pathological bone tissue.
Eren E, Nijhuis W, van der Weel F, Eren A, Ansari S, Bomans P
Microsc Res Tech. 2021; 85(2):469-486.
PMID: 34490967
PMC: 9290679.
DOI: 10.1002/jemt.23920.
Superior Alignment of Human iPSC-Osteoblasts Associated with Focal Adhesion Formation Stimulated by Oriented Collagen Scaffold.
Ozasa R, Matsugaki A, Matsuzaka T, Ishimoto T, Yun H, Nakano T
Int J Mol Sci. 2021; 22(12).
PMID: 34207766
PMC: 8228163.
DOI: 10.3390/ijms22126232.
Knock-Out Zebrafish Recapitulate β3GalT6-Deficiency Disorders in Human and Reveal a Trisaccharide Proteoglycan Linkage Region.
Delbaere S, De Clercq A, Mizumoto S, Noborn F, Bek J, Alluyn L
Front Cell Dev Biol. 2020; 8:597857.
PMID: 33363150
PMC: 7758351.
DOI: 10.3389/fcell.2020.597857.
Deciphering the Relevance of Bone ECM Signaling.
Alcorta-Sevillano N, Macias I, Infante A, Rodriguez C
Cells. 2020; 9(12).
PMID: 33297501
PMC: 7762413.
DOI: 10.3390/cells9122630.
4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts.
Takeyari S, Kubota T, Ohata Y, Fujiwara M, Kitaoka T, Taga Y
J Biol Chem. 2020; 296:100027.
PMID: 33154166
PMC: 7948972.
DOI: 10.1074/jbc.RA120.014709.